SCHEMBL5835960

SCHEMBL5835960

CCOC(=O)CC(=O)Nc1ncc(Br)s1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.62
MAPK10 P53779 1/20 0.62
MAPT P10636 2/20 0.55
GAA P10253 1/20 0.55
CCNE1 P24864 2/20 0.53
CDK2 P24941 2/20 0.53
CDK5 Q00535 1/20 0.53
LMNA P02545 1/20 0.53
ALDH1A1 P00352 3/20 0.52
MAPK1 P28482 1/20 0.52
SETD1B Q9UPS6 1/20 0.49
CCNB2 O95067 1/20 0.49
CCNE2 O96020 1/20 0.49
CDK1 P06493 1/20 0.49
CDK4 P11802 1/20 0.49
CCNB1 P14635 1/20 0.49
CCND1 P24385 1/20 0.49
CCNB3 Q8WWL7 1/20 0.49
PKM P14618 1/20 0.48
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835589 0.89 SMN1; SMN2 (0.67) SMN1; SMN2MAPK10MAPTGAACCNE1
SCHEMBL5835696 0.87 SMN1; SMN2 (0.56) SMN1; SMN2MAPK10MAPTGAACCNE1
SCHEMBL29003794 0.83 MAPT (0.55) SMN1; SMN2MAPTGAACCNE1CDK2
SCHEMBL17353987 0.82 SMN1; SMN2 (0.72) SMN1; SMN2MAPK10CCNE1CDK2CDK5
SCHEMBL5842781 0.81 SMN1; SMN2 (0.63) SMN1; SMN2MAPK10MAPTGAACCNE1
SCHEMBL5835735 0.79 SMN1; SMN2 (0.83) SMN1; SMN2MAPK10CCNE1CDK2CDK5
SCHEMBL70693 0.78 CCNE1 (0.63) SMN1; SMN2MAPTGAACCNE1CDK2
SCHEMBL5835100 0.77 SMN1; SMN2 (0.70) SMN1; SMN2MAPK10MAPTCCNE1CDK2
SCHEMBL5836346 0.77 SMN1; SMN2 (0.65) SMN1; SMN2MAPK10MAPTCCNE1CDK2
SCHEMBL6729 0.74 CCNE1 (0.59) SMN1; SMN2MAPK10MAPTCCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4416156-A1 COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING Remix Therapeutics Inc. (US) 2024-08-21 EP disclosed
CN-116134036-A Compounds and methods for modulating splicing 雷密克斯医疗公司 2023-05-16 CN disclosed
WO-2023064879-A1 COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING REMIX THERAPEUTICS INC. (US) 2023-04-20 WO disclosed
EP-4132936-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2023-02-15 EP disclosed
US-7037929-B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents PHARMACIA & UPJOHN S.P.A. (IT) 2006-05-02 US disclosed
CN-1325389-A 2-aminothiazole derivatives, process for preparing the same and their use as antitumor agents PHARMACIA & UPJOHN SPA (IT) 2001-12-05 CN disclosed
EP-1124810-A1 2-AMINO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2001-08-22 EP disclosed
WO-2000026202-A1 2-AMINO-THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-05-11 WO disclosed